Internal Medicine · Saint Louis, MO
NPI
1386653731
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
4
Medicare group memberships
Hospitals
0
Hospital affiliations
7721 Clayton Rd
Saint Louis, MO, 63117
Phone (314) 546-6072
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.6M
12,041 services
Medicare patients, 2024
216
Average age 60
Drug cost, 2024
$982K
20,757 prescriptions
Company payments, 2023
$41.85
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paul S Catanzaro was code J1100 (injection, dexamethasone sodium phosphate, 1 mg), 5,169 times for 171 patients. In total Paul S Catanzaro billed 12,041 services in 53 codes, and Medicare paid $3.6M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 5,169 | 171 | $0.09 | $454 |
| 99213 Office E&M - Established | Office | 2,227 | 192 | $65.35 | $146K |
| 90834 Psychotherapy - Nongroup | Office | 413 | 81 | $73.86 | $31K |
| 64450 Musculoskeletal | Office | 359 | 111 | $55.18 | $20K |
| 20610 Joint Injection | Office | 151 | 56 | $47.25 | $7,135 |
| 27096 Joint Injection | Office | 148 | 95 | $121.68 | $18K |
| 64493 Nerve Block Injection - Back | Office | 125 | 77 | $134.21 | $17K |
| 64494 Nerve Block Injection - Back | Office | 120 | 74 | $70.46 | $8,455 |
| 20551 Musculoskeletal | Office | 103 | 49 | $40.63 | $4,184 |
| 95921 Electrical Nerve Conductivity | Office | 96 | 91 | $66.51 | $6,385 |
| 95923 Electrical Nerve Conductivity | Office | 95 | 91 | $91.59 | $8,701 |
| 92540 Vision, Hearing, and Speech Services | Office | 94 | 82 | $80.90 | $7,604 |
| 92546 Vision, Hearing, and Speech Services | Office | 94 | 82 | $99.27 | $9,331 |
| 92547 Vision, Hearing, and Speech Services | Office | 91 | 79 | $7.95 | $723 |
| 64483 Nerve Block Injection - Back | Office | 85 | 54 | $185.34 | $16K |
By year: 2022 $419K for 10,461 services; 2023 $329K for 9,225 services; 2024 $3.6M for 12,041 services.
Medicare prescription drug claims, 2024
In 2024, the drug Paul S Catanzaro prescribed most often to Medicare patients was Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen), with 3,479 prescriptions and refills. In total Paul S Catanzaro wrote 20,757 Medicare prescriptions that cost $982K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 3,479 | 3,479 | 285 | $61K |
| Baclofen Generic | 2,267 | 2,267 | 262 | $15K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 2,214 | 2,214 | 229 | $39K |
| Gabapentin Generic | 1,493 | 1,494 | 147 | $8,870 |
| Lidocaine Generic | 1,230 | 1,234 | 280 | $28K |
| Diclofenac Sodium Er Diclofenac Sodium | 887 | 890 | 159 | $47K |
| Cyclobenzaprine Hcl Generic | 762 | 762 | 72 | $5,603 |
| Omega-3 Acid Ethyl Esters Generic | 628 | 640 | 96 | $54K |
| Ropinirole Hcl Generic | 552 | 554 | 54 | $1,823 |
| Tizanidine Hcl Generic | 509 | 509 | 52 | $3,150 |
| Diclofenac Sodium Generic | 505 | 508 | 171 | $16K |
| Naloxone Hcl Generic | 483 | 483 | 200 | $25K |
| Butalbital-Acetaminophen-Caffe Butalb/Acetaminophen/Caffeine | 456 | 456 | 115 | $7,167 |
| Hydroxyzine Hcl Generic | 369 | 371 | 48 | $6,735 |
| Vascepa Icosapent Ethyl | 356 | 360 | 97 | $126K |
Brand drugs: - claims; generic drugs: 20,067 claims; opioid claims: 6,183.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Paul S Catanzaro $41.85 ($41.85 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbvie Inc. with $41.85.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 2 | $41.85 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.